Glucocorticoid receptor activation inhibits chemotherapy-induced cell death in high-grade serous ovarian carcinoma.
Stringer-Reasor et al. • 2015 • Gynecol Oncol. 2015;138(3):656-62.
© 2024 Corcept Therapeutics, Incorporated
A novel combined glucocorticoid-mineralocorticoid receptor selective modulator markedly prevents weight gain and fat mass expansion in mice fed a high-fat diet.
Mammi et al. • 2016 • Int J Obes (Lond). 2016;40(6):964-72.
Glucocorticoid receptor activity contributes to resistance to androgen-targeted therapy in prostate cancer.
Isikbay et al. • 2014 • Horm Cancer. 2014;5(2):72-89.
Identification of a selective glucocorticoid receptor modulator that prevents both diet-induced obesity and inflammation.
van den Heuvel et al. • 2016 • Br J Pharmacol. 2016;173(11):1793-804.
Glucocorticoid receptor antagonism as a novel therapy for triple-negative breast cancer.
Skor et al. • 2013 • Clin Cancer Res. 2013;19(22):6163-72.
Glucocorticoid antagonism limits adiposity rebound and glucose intolerance in young male rats following the cessation of daily exercise and caloric restriction.
Teich et al. • 2016 • Am J Physiol Endocrinol Metab. 2016;311(1):E56-68.
Effects of selective and non-selective glucocorticoid receptor II antagonists on rapid-onset diabetes in young rats.
Beaudry et al. • 2014 • PLoS One. 2014;9(3):e91248.
Development and validation of an immunohistochemistry assay to assess glucocorticoid receptor expression for clinical trials of mifepristone in breast cancer.
Baker et al. • 2015 • Cancer Manag Res. 2015;7:361-8.
A randomized phase I trial of nanoparticle albumin bound paclitaxel (nab-paclitaxel, Abraxane®) with or without mifepristone for advanced breast cancer
Nanda et al. • 2013 • Cancer Res 2013;73(24 Suppl): Abstract nr P2-16-21.
Glucocorticoid receptors in the prefrontal cortex regulate dopamine efflux to stress via descending glutamatergic feedback to the ventral tegmental area.
Butts KA, Phillips AG. • 2013 • Int J Neuropsychopharmacol. 2013;16(8):1799-807.